Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Farde

Showing results (191-200 of 218) with videos related to

Pageof 22
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2014
(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET StudySjoerd J Finnema, Vladimir Stepanov, Ryuji Nakao, et al.
Clinical and Translational Science|February 22, 2023
Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non-small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging studySimon Ekman, Zsolt Cselényi, Andrea Varrone, et al.
Molecular Imaging and Biology|September 5, 2013
Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primatesMagnus Schou, Katarina Varnäs, Johan Sandell, et al.
Brain, Behavior, and Immunity|January 29, 2016
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjectsNaoki Kanegawa, Karin Collste, Anton Forsberg, et al.
Molecular Imaging and Biology|September 19, 2008
Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and ratsMagnus Schou, Sami S Zoghbi, H Umesha Shetty, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 20, 2003
NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traitsAndrea Carmine, Silvia Buervenich, Dagmar Galter, et al.
Molecular Psychiatry|November 11, 2021
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysisPontus Plavén-Sigray, Pauliina Ikonen Victorsson, Alexander Santillo, et al.
EJNMMI Research|December 28, 2018
The development of a GPR44 targeting radioligand [<sup>11</sup>C]AZ12204657 for in vivo assessment of beta cell massMahabuba Jahan, Peter Johnström, Ram K Selvaraju, et al.
Journal of Neurochemistry|August 29, 2015
Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's diseaseBin Ji, Chun-Jen Chen, Kazunori Bando, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2013
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patientsAnton Forsberg, Anders Juréus, Zsolt Cselényi, et al.
Pageof 22

Showing results (191-200 of 218) with videos related to

Sort By:
Pageof 22
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2014
(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET StudySjoerd J Finnema, Vladimir Stepanov, Ryuji Nakao, et al.
Clinical and Translational Science|February 22, 2023
Brain exposure of osimertinib in patients with epidermal growth factor receptor mutation non-small cell lung cancer and brain metastases: A positron emission tomography and magnetic resonance imaging studySimon Ekman, Zsolt Cselényi, Andrea Varrone, et al.
Molecular Imaging and Biology|September 5, 2013
Synthesis, radiolabeling, and in vivo pharmacokinetic evaluation of the amyloid beta radioligand [11C]AZD4694 in nonhuman primatesMagnus Schou, Katarina Varnäs, Johan Sandell, et al.
Brain, Behavior, and Immunity|January 29, 2016
In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjectsNaoki Kanegawa, Karin Collste, Anton Forsberg, et al.
Molecular Imaging and Biology|September 19, 2008
Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and ratsMagnus Schou, Sami S Zoghbi, H Umesha Shetty, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|June 20, 2003
NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traitsAndrea Carmine, Silvia Buervenich, Dagmar Galter, et al.
Molecular Psychiatry|November 11, 2021
Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysisPontus Plavén-Sigray, Pauliina Ikonen Victorsson, Alexander Santillo, et al.
EJNMMI Research|December 28, 2018
The development of a GPR44 targeting radioligand [<sup>11</sup>C]AZ12204657 for in vivo assessment of beta cell massMahabuba Jahan, Peter Johnström, Ram K Selvaraju, et al.
Journal of Neurochemistry|August 29, 2015
Distinct binding of amyloid imaging ligands to unique amyloid-β deposited in the presubiculum of Alzheimer's diseaseBin Ji, Chun-Jen Chen, Kazunori Bando, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 18, 2013
Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patientsAnton Forsberg, Anders Juréus, Zsolt Cselényi, et al.
Pageof 22